The development history of Jinger

From 2000 to 2004, the company was in the transformation and development stage of hospital preparations scientific research achievements.

In 2000, a team of experts from Beijing Jinger Medical Research Institute began to form. Jinger Medical Research Institute brought together top experts in the field of children's health care in China, such as Beijing Children's Hospital, Children's Hospital affiliated to Capital Pediatric Research Institute, Peking University Women and Children's Hospital and Beijing Maternity Hospital, and established Jinger Expert Committee. From 2000 to 2004, the company carried out scientific research transformation on the in-hospital preparation achievements of Beijing Children's Hospital and Capital Institute of Pediatrics, and registered the product achievements for the second time according to the approval standards of the US Food and Drug Administration.

From 2005 to 2009, the company listed three products and established a national sales network.

At the beginning of 2005, Jinger five-dimensional lysine oral solution medicine was listed, and hundreds of maternal and child health hospitals and children's hospitals were developed nationwide. At the beginning of 2005, Jingerxin chewable health food was successfully registered. In 2007, Jingerwei D calcium granule health food was successfully registered. From 2005 to 2009, the company set up five sales divisions nationwide to radiate the national market.

From 20 10 to 20 1 1, the company established the strategy of "health care for older children" and became the leader of children's health care in China.

On 20 10, the company reorganized its shares, and Beijing Shoutongxin Pharmaceutical Technology Development Co., Ltd. (a subsidiary of Capital Pediatric Research Institute) was renamed as Beijing Jinger Pharmaceutical Technology Co., Ltd., and on 20 10, Beijing Jinger Hospital Management Co., Ltd. was registered and established, thus establishing the national child health care strategy of opening 100 Jinger children health care centers throughout the country. 20 1 1, the company acquired Beijing askelai bioengineering company with a registered capital of 30 million yuan, entered the field of basic medical clinical laboratory, and developed a series of pediatric clinical laboratory products, providing strategic support for the group's "health care for older children" strategy. On 20 1 1 year, Jinger group was formally established with Beijing Jinger Medical Research Institute as the main body and Beijing Jinger Medical Technology Co., Ltd., Beijing Askeley Bioengineering Company and Beijing Jinger Hospital Management Co., Ltd. as subsidiaries. 20 1 1 year, 20 products such as oral liquid, granules, tablets and ointments are on the market.

2065 438+02- Fine operation of Jinger health care products sales market.

At the beginning of 20 12, six hospitals of Jinger Hospital in Henan and Shandong were put into operation. Jinger Health Center integrates the resources of the hospital's child care department, early education center, children's training and rehabilitation center, parent-child park, maternal and child store, etc., and provides professional and humanized child health care services for middle and high-end parents.